期刊文献+

内蒙古镶黄旗地区妇女宫颈病变筛查现状 被引量:10

Status of cervical lesion screening of women living in Xianghuangqi of Neimenggu province
下载PDF
导出
摘要 目的探讨宫颈细胞学(包括巴式涂片及超柏氏薄层液基细胞学)及阴道镜检查筛查内蒙古镶黄旗地区妇女宫颈病变的现状及临床意义。方法2004年7月至2009年1月对内蒙古镶黄旗地区的642例28~67岁有性生活妇女进行宫颈病变筛查,其中557例妇女行传统宫颈巴式涂片法,85例妇女行宫颈超柏氏薄层液基细胞学,并对宫颈细胞学异常者(≥ASCUS)行阴道镜检查及活检。结果642例妇女中宫颈细胞学阳性(≥ASCUS)者34例,占5.3%(34/642),其中ASCUS者22例,占64.7%(22/34);低度鳞状上皮内病变(LSIL)者6例,占17.6%(6/34);高度鳞状上皮内病变(HSIL)者6例,占17.6%(6/34),其中有1例肯定为宫颈癌。宫颈细胞学阴性608例,占94.7%(608/642)。宫颈细胞学阳性34例人群中,行阴道镜活检病理检查者有25例,其中慢性宫颈炎13例(52.0%);CIN1为5例(20.0%);CIN2为4例(16.0%);CIN3为1例(4.0%);浸润癌为2例(8.0%)。结论应重视并及时进行经济不发达地区妇女人群宫颈病变的早期筛查,传统宫颈巴式涂片法及阴道镜活检及病理学检查为可行的筛查方法,有条件者可进行宫颈薄层液基细胞学结合阴道镜活检及病理学检查,对提高早期宫颈癌筛查的准确性效果明显。对内蒙古等西部地区,应在完善技术力量支持、筛查质量控制、建立筛查后的转诊制度及治疗的绿色通道等方面,以降低宫颈癌的发病率。 Objective To analysis the value of cytology and colposcopy in cervical lesion screening of women living in Xianghuangqi of Neimenggu province.Methods A total of 642 women at their 28~67 age who living in Xianghuangqi of Neimenggu province were screened for cervical lesion. Among them, 557 women were sampled cervical papsmear and the other 85 women were sampled cervical cytology (LCT). Colposcopy and biopsy were conducted in women with positive cytology. Results Among the 642 women, the positive rate of cytology (≥ASCUS) was 5.3% (34/642). Except 9 women who refused to take colposcopy, among the other 25 women with positive cervical cytology, 2 invasive cervical cancer, 1 CIN3, 4 CIN2 and 5 CIN1 were found out.Conclusions We should pay more attention to cervical lesion screening of people living in poor health condition area.Combined analysis of cytology and colposcopy provides very helpful information for the screening of cervical lesion.
出处 《中国妇产科临床杂志》 2010年第2期95-97,共3页 Chinese Journal of Clinical Obstetrics and Gynecology
基金 卫生部面向农村和城市社区推广适宜技术十年百项计划中北方地区人群子宫颈癌筛查及早诊早治技术推广计划课题
关键词 宫颈癌筛查 宫颈细胞学 阴道镜检查 cervical lesion screening cervical cytology colposcopy
  • 相关文献

参考文献10

  • 1Parkin DM. The global health burden ofinfection- associated cancers in the year 2002. Int J Cancer, 2006, 118:3030 - 3044.
  • 2Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer, 2001, 94: 153- 156.
  • 3Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics 2002. CA Cancer J Clin, 2005, 55: 74 - 108.
  • 4PAN Q, Belinson JL, Li L, et al. A thin - layer, liquid - based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross - sectional, comparative study. Acta Cytol, 2003, 47:45-50.
  • 5Cochand, Vincent S, Vielh, et al. Cytopathology in france. Cytopathology, 2004,15:163 - 166.
  • 6Maria Lu'cia Utagawa, So'niaMariaMiranda Pereira. Pap test in a high risk population comparison of conventional and liquid2base. Cytology Diagnostic Cytopathology, 2004, 31:169 - 172.
  • 7Wu SF, Li M, Wang SX, et al. A comparison of four screening methods for cervical neop lasia. International Journal of Gynecology &Obstetrics, 2005, 91:189 - 193.
  • 8Ring M, Bolger N, O'Donnell M, et al. Evaluation of liquid2based cytology in cervical screening of high2risk populations: asp lit study of colposcopy and genito2urinary medicine populations. Cytopathology, 2002, 13: 152- 159.
  • 9Benedet JL. Staging classification and clinical practice Guidelines for gynecological cancer. A collaboration between FIGO and IGCS. 3th ed, 2006: 37- 58.
  • 10魏丽惠.再谈子宫颈癌相关的几个问题[J].中国妇产科临床杂志,2008,9(2):83-83. 被引量:11

二级参考文献8

  • 1屠铮,李静,赵超,宋丹,崔淑慧,章文华,乔友林,Belinson JL,魏丽惠.醋白肉眼观察试验在宫颈病变筛查中的价值[J].中国妇产科临床杂志,2007,8(2):90-92. 被引量:25
  • 2[1]Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics.CA Cancer J Clin,2002,55:74-108.
  • 3[2]World He alth Organization.Comperehensive cervical cancer contrl-A guide to essential practice.2006.
  • 4[3]Cuzick J,Clavel C,Petry KU,et al.Overview of the European and North American studies on HPV testing in primary cervical cancer screening.Int J Cacer,2006,119:1095-1101.
  • 5[4]董志伟.中国癌症筛查及早诊早治指南(试行).北京大学医学出版社,2003.9-20.
  • 6[7]Cutts FT,Franceschi S,Goldie S,et al.Human papillomavirus and HPV vaccines:a review.Bull World Health Organ,2007,85:719-726.
  • 7[8]Harper DM,Franco EL,Wheeler CM,et al,Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18:follow-up from a randomised control trial.Lancet,2006,367:1247-1255.
  • 8乔友林,章文华,李凌,潘秦镜,杨玲,吴令英,戍寿德,李爱玲,张询,任生达,Belinson J.子宫颈癌筛查方法的横断面比较研究[J].中国医学科学院学报,2002,24(1):50-53. 被引量:351

共引文献10

同被引文献53

引证文献10

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部